The Short Answer Is "It Depends"
Peptides are not one legal category. A cosmetic serum, an FDA-approved injectable, a compounded prescription, and a vial labeled "for research use only" can all contain peptides and sit under completely different rules.
Regulation in this area also changes often. Several peptides have moved between restricted and permitted lists within a few years. Treat everything below as a framework for understanding, not as legal advice, and check current sources before acting.
The Five Buckets
1. Cosmetic peptides
Peptides in skincare (like Matrixyl or Argireline) are regulated as cosmetics. They are sold freely, but brands are limited in the health claims they can make, and there is no requirement to prove efficacy before launch.
2. Dietary supplement peptides
Collagen peptides and similar oral products are regulated as foods or supplements. They do not need pre-market approval, but must not claim to treat disease.
3. FDA-approved peptide drugs
These went through full clinical development and carry an approved label. Examples include semaglutide and tirzepatide, PT-141 (Vyleesi), and tesamorelin. They need a prescription and are manufactured under pharmaceutical quality controls.
4. Compounded peptides
Licensed pharmacies can prepare customized medications under a prescription, but only from ingredients that meet FDA criteria. This is where the "categories" come in.
5. "Research use only" peptides
Sold by online vendors with labels such as "not for human consumption." This is a legal shield for the seller, not a regulatory approval. These products have no oversight of purity, sterility, or dosing.
FDA Compounding Categories in Plain English
Two rulebooks matter here. Section 503A covers pharmacies compounding for individual prescriptions. Section 503B covers outsourcing facilities that make larger batches. For ingredients not in an approved drug or a pharmacopeia monograph, the FDA sorts nominated bulk substances into categories:
| Category | Meaning in practice |
|---|---|
| On the 503A bulks list | Formally eligible for pharmacy compounding |
| Category 1 | Nominated with enough information to evaluate; the FDA does not intend to take enforcement action against compounders while it reviews, if conditions are met |
| Category 2 | The FDA has identified significant safety concerns and may take enforcement action |
| Category 3 | Nominated with too little information to evaluate; the FDA may take enforcement action |
A peptide's category can change, and 2026 shows how quickly:
- April 2026. The FDA removed 12 substances from Category 2 after their nominators withdrew the nominations, not because of a new safety finding. They include BPC-157, TB-500, Epithalon, Semax, KPV, MOTS-c, DSIP, LL-37, Melanotan II, PEG-MGF, Dihexa, and injectable GHK-Cu. Removal is not approval, and it does not put a substance on the 503A bulks list
- July 2026. The FDA's Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157, TB-500, KPV, MOTS-c, Epithalon, and Semax to the 503A bulks list, and voted against DSIP (emideltide). These votes are non-binding, and HHS has not finalized them. A second meeting on further peptides is expected by February 2027
- Still on Category 2 as of April 22, 2026: GHRP-2 and GHRP-6 (503B), Ipamorelin (503B only), MK-677 (503A and 503B), and Kisspeptin-10 (503A). CJC-1295 is not currently on the list
Each peptide profile on this site now carries a dated regulatory-status box. Always verify against the FDA's current bulk drug substances pages, because this area changes often.
Important: a category move is a compounding-access decision. It is not an approval. Even a peptide on a permitted list is still an unapproved drug in the sense that no one has proven it safe and effective for a specific use.
"Legal to Possess" vs "Legal to Sell"
These are different questions.
- Possession. Most research peptides are not controlled substances, and personal possession is generally not prosecuted. That is not the same as the product being legal to sell for human use
- Selling for human use. Marketing an unapproved peptide as a treatment or supplement can violate drug and supplement laws. Enforcement has focused on sellers and clinics rather than individual buyers, but that can change
- Importing. Ordering from overseas adds customs and seizure risk on top of quality risk
Rebranding does not solve this. When a restricted peptide's sequence is sold under a new name, as happened with Pentadeca Arginate, regulators have not necessarily evaluated that name separately, and a seller calling it "legal" is making a claim nobody has confirmed.
Sports: A Separate Rulebook
Even where a peptide is accessible, anti-doping rules are independent of drug law. The World Anti-Doping Agency (WADA) prohibits many peptide hormones, growth factors, and related substances, including BPC-157, TB-500, and growth hormone secretagogues like Ipamorelin, Sermorelin, and MK-677.
If you compete in any tested sport, from professional to masters-level events, assume a peptide is prohibited until you have checked your governing body's current list. "It's legal where I bought it" is not a defense in a doping case.
Outside the United States
Rules differ widely. A few patterns:
- Some peptides are approved drugs in other countries but not in the US (for example, Thymosin Alpha-1 in many Asian markets)
- Some countries treat unapproved peptides as medicines and restrict import or sale far more strictly than the US
- The EU generally requires medicinal authorization for products making therapeutic claims
If you live outside the US, local regulator websites are the only reliable source.
How to Check the Current Status
- Look up the peptide in the FDA's bulk drug substances lists for 503A compounding
- Check whether it has an approved drug label (Drugs@FDA)
- For sport, search the current WADA Prohibited List
- Ask your prescriber or pharmacist which lists they follow, and why they do or do not offer a given peptide
- Read the peptide's profile on this site for the status we last tracked, and note its update date
Practical Takeaways
- "Peptide" is not a legal category. Cosmetic, supplement, approved drug, compounded drug, and research chemical all follow different rules
- "Research use only" is a seller's disclaimer, not a safety standard
- Compounding categories change. Several peptides moved in 2026 alone. Never assume a status from an old forum post, a vendor page, or a profile that has no date
- A name change is not a legal change
- Athletes should assume peptides are banned until their governing body says otherwise
- A legitimate prescriber and a licensed pharmacy are the main protection you have if you decide to pursue a compounded peptide